Crinetics Pharmaceuticals CRNX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's operating cash flow?
- Crinetics Pharmaceuticals (CRNX) reported operating cash flow of -$124.7M in Q1 2026.
- How has Crinetics Pharmaceuticals's operating cash flow changed year-over-year?
- Crinetics Pharmaceuticals's operating cash flow decreased by 41.0% year-over-year, from -$88.45M to -$124.7M.
- What is the long-term trend for Crinetics Pharmaceuticals's operating cash flow?
- Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's operating cash flow has grown at a 43.7% compound annual growth rate (CAGR), from -$88.59M to -$377.92M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.